November 20, 2019
  • November 20, 2019
Breaking News
  • Home
  • Markets
  • UBS Group AG (NYSE:UBS) compliance officer convicted of an additional insider trading count

UBS Group AG (NYSE:UBS) compliance officer convicted of an additional insider trading count

By on June 27, 2019 0

A former UBS Group AG (NYSE:UBS) compliance officer and her friend were each convicted of an additional insider trading count, a day after the London jury found them guilty of three other charges. The panel is still deliberating a final count against both ex-UBS employee Fabiana Abdel-Malek, 36, and day trader Walid Choucair, 40, in the case, which involves charges from between June 2013 and June 2014.



UBS Group AG (NYSE:UBS) shares gained 0.86% to finally closed at $11.68 in last active session. 

UBS’s distance from 20 day simple moving average is 0.05% and distance from 50-Day simple moving average is -4.44%.

Analyst’s mean target price for UBS is $17.53. Stock value has moved between $11.34 – 16.69 in last one year. Stock has got OUTPERFORM rating from 0 of Thomson Reuters analysts, 0 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for UBS is $17.53. 

UBS Group AG (NYSE:UBS) yearly performance is -23.36%. Annual EPS Growth of past 5 years is 7.30%. The current share price indicates that stock is -29.98% away from its one year high and is moving 3.18% ahead of its 52-week low. 



On 26 June 2018, SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares shed -0.78% and ultimately finalized to $0.13 in last traded day. Stock has got OUTPERFORM rating from 1 of Thomson Reuters analysts, 1 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for SLS is $8.75 while analysts mean recommendation is 2.00. 



At the movement Allergan plc (NYSE:AGN) is under coverage by number of analysts. Buy rating has been given by 7 analysts to the company stock whereas 0 given UNDERPERFORM rating to stock and 13 given HOLD rating. The consensus recommendation by Thomson Reuters analysts is outperform and their mean rating for the stock is 2.24 on scale of 1-5. Analysts mean target price for Allergan plc(NYSE:AGN) is $177.60 while their mean recommendation is 2.20 (1=Buy, 5=sell). 

If we look at stock performance in last active day trading, we see that stock has moved gained 0.97% to end the day at $164.00. The current share price indicate that stock is -16.75% away from its one year high and is moving 43.52% ahead of its 52-week low. 

Leave a comment